Drugplain

BOSULIF 50 mg/1

Bosutinib · CAPSULE · Pfizer Laboratories Div Pfizer Inc

No Recall History
Plain English

BOSULIF is a capsule containing bosutinib at 50 mg/1, taken oral. Manufactured by Pfizer Laboratories Div Pfizer Inc.

Key Facts

Brand Name
BOSULIF
Generic Name
Bosutinib
NDC Code (Product)
0069-0504
Manufacturer
Pfizer Laboratories Div Pfizer Inc
Strength
50 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
NDA217729
Marketing Start
01/02/2024

Recall History

No Recall History

Frequently Asked Questions

What is BOSULIF used for?

BOSULIF contains Bosutinib. It is a capsule taken oral. Consult your doctor for specific uses.

Is BOSULIF a controlled substance?

BOSULIF is not classified as a controlled substance by the DEA.

What is the generic name for BOSULIF?

The generic name for BOSULIF is Bosutinib. There are 4 other brand versions of Bosutinib.

What is the NDC code for BOSULIF 50 mg/1?

The NDC (National Drug Code) for BOSULIF 50 mg/1 is 0069-0504, listed by Pfizer Laboratories Div Pfizer Inc.

Product NDC

0069-0504

Package NDC

0069-0504-30

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)